Laboratory services have transformed from routine diagnostics to specialized testing, achieving notable advancements from 2017 to 2023. With a skilled team of 18 pathologists, we established eight specialized sections: chemical pathology, hematology, histopathology, microbiology, immunology, cytogenetics, molecular pathology, and a biorepository. We project that over 176,400+ patients will benefit from clinical laboratory services. We are accredited by the College of American Pathologists (CAP), that highlights our commitment to excellence in laboratory services.
“At IHHN, we aim to bridge the diagnostic access gap by establishing a world-class facility that provides state-of-the-art diagnostics to all patients, regardless of their financial situation. Our vision for the new building is to create an integrated clinical laboratory and research hub that supports accurate diagnoses, promotes translational research, and attracts international grants, especially in resource-constrained countries. International clinical diagnostics have advanced significantly in areas such as molecular pathology, cytogenetics, microbiology, cancer diagnostics, and transplant immunology.”
“At IHHN, we aim to bridge the diagnostic access gap by establishing a world-class facility that provides state-of-the-art diagnostics to all patients, regardless of their financial situation. Our vision for the new building is to create an integrated clinical laboratory and research hub that supports accurate diagnoses, promotes translational research, and attracts international grants, especially in resource-constrained countries. International clinical diagnostics have advanced significantly in areas such as molecular pathology, cytogenetics, microbiology, cancer diagnostics, and transplant immunology.”